ArticleInternational journal of clinical practice2022
Adherence to Medication among Parkinson's Disease Patients Using the Adherence to Refills and Medications Scale.
Article in International journal of clinical practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 18 citations in OpenAlex.
- Parkinson's disease severity and treatment classification in interpreting bisphosphonate-associated fracture risk.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026Article
- Longitudinal Dynamics of Physical Function With Anxiety and Depression in Parkinson's Disease: A Cross-Lagged Panel Analysis of the PPMI Dataset.Brain and behavior · 2026Article
- Continuity of care combined with TCM acupoint application improves blood pressure control and quality of life in elderly hypertensive patients: a retrospective study with bootstrap mediation analysis.American journal of translational research · 2026Article
- Adherence and persistence with istradefylline treatment in patients with Parkinson's disease in the United States.Frontiers in pharmacology · 2025Article
- Apathy in Parkinson's Disease: A Diagnostic Conundrum Explored in a Cohort Characterization Study.The Journal of neuropsychiatry and clinical neurosciences · 2025Article
- Determining Medication Adherence in Patients Treated for Parkinson's Disease and Related Factors.Parkinson's disease · 2025Article
- The role of nurses for patients with Parkinson's disease at home: a scoping review.BMC nursing · 2024Article
- Medication adherence and costs of medical care among patients with Parkinson's disease: an observational study using electronic medical records.BMC public health · 2024Observational
- A real-world analysis of pharmacotherapy adherence and the factors influencing it in Serbia: a nationwide, population-based, cross-sectional study.Frontiers in public health · 2024Article
- Therapeutic singing and expiratory muscle strength training in Parkinson's disease: a mixed methods comparison.Frontiers in rehabilitation sciences · 2024Article
- Perceived Discrimination in Health Care for LGBTQIA+ People Living With Parkinson's Disease.The journals of gerontology. Series B, Psychological sciences and social sciences · 2023Article
- Association between apathy in patients with maintenance dialysis and hospitalization or mortality: a prospective cohort study.Frontiers in psychiatry · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Adherence to medication is an important factor that can influence Parkinson's disease (PD) control. We aimed to explore patients' adherence to antiparkinsonian medication and determine factors that might affect adherence to medications among PD patients. Methods: A cross-sectional, exploratory survey of PD patients treated with at least one antiparkinsonian drug and with a total score of MoCA (Montreal Cognitive Assessment) ≥26 was conducted. The final sample included 112 PD patients. A patient's adherence was assessed through ARMS (Adherence to Refills and Medications Scale). ARMS scores higher than 12 were assumed lower adherence. In addition, each patient underwent neurological examination, assessment of depression, anxiety, and evaluation of the presence of PD nonmotor symptoms. Results: The mean ARDS value in our cohort was 14.9 ± 2.5. Most PD patients (74.1%) reported lower adherence to their medication. Participants in the lower adherence group were younger at PD onset, had significantly higher UPDRS (Unified PD Rating Scale) scores, as well as UPDRS III and UPDRS IV subscores, HARS (Hamilton Anxiety Rating Scale), and NMSQuest (Non-Motor Symptoms Questionnaire for PD) scores compared to the fully adherent group ( Conclusion: Depressed PD patients compared to PD patients without clinical depression had a three times higher risk for lower adherence to pharmacotherapy. Recognition and adequate treatment of depression might result in improved adherence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.